Thorvardur Halfdanarson
MD
Professor of Oncology
👥Biography 个人简介
Thorvardur Halfdanarson at Mayo Clinic is a neuroendocrine tumor specialist with extensive expertise in peptide receptor radionuclide therapy (PRRT). He contributed to the NETTER-1 trial demonstrating lutetium-177-DOTATATE benefit in midgut NETs, and has led real-world outcome studies of PRRT in the United States. His research on PRRT combinations, sequencing, and outcome optimization has shaped NET treatment guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Thorvardur Halfdanarson 的研究动态
Follow Thorvardur Halfdanarson's research updates
留下邮箱，当我们发布与 Thorvardur Halfdanarson（Mayo Clinic）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment